COVID-19 Clinical Programme Update
18 déc. 2020 02h00 HE
|
Synairgen plc
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) COVID-19 Clinical Programme Update SNG001 given Fast Track designation and IND cleared by the US FDAPhase III trial design adapted which...
Synairgen plc - Interim results for the six months ended 30 June 2020
29 sept. 2020 07h00 HE
|
Synairgen plc
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Interim results for the six months ended 30 June 2020 Southampton, UK – 29 September 2020: Synairgen plc (LSE: SNG), the respiratory drug...
Synairgen announces positive data from interim analysis of SNG001 trial in COPD patients
08 sept. 2020 07h00 HE
|
Synairgen plc
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Synairgen announces positive data from interim analysis of SNG001 trial in COPD patients SNG001 well tolerated in this older population...
Synairgen announces positive results from trial of SNG001 in hospitalised COVID-19 patients
20 juil. 2020 07h00 HE
|
Synairgen plc
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Synairgen announces positive results from trial of SNG001 in hospitalised COVID-19 patients Patients who received SNG001 had a 79% lower...
Synairgen announces positive results from trial of SNG001 in hospitalised COVID-19 patients
20 juil. 2020 02h01 HE
|
Synairgen plc
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Synairgen announces positive results from trial of SNG001 in hospitalised COVID-19 patients Patients who received SNG001 had a 79%...
Synairgen Completes Recruitment of Hospitalised Patients in COVID-19 Trial
28 mai 2020 07h00 HE
|
Synairgen plc
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Synairgen Completes Recruitment of Hospitalised Patients in COVID-19 Trial Southampton, UK – 28 May 2020: Synairgen plc (LSE: SNG), the...
Synairgen plc - Update on expanded SG016 trial for patients with COVID-19:Synairgen initiates dosing of SNG001 in home setting to treat patients earlier in the illness
26 mai 2020 07h00 HE
|
Synairgen plc
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Update on expanded SG016 trial for patients with COVID-19:Synairgen initiates dosing of SNG001 in home setting to treat patients earlier in...
Synairgen plc: Preliminary results for the year ended 31 December 2019
26 mai 2020 07h00 HE
|
Synairgen plc
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Preliminary results for the year ended 31 December 2019 Southampton, UK – 26 May 2020: Synairgen plc (LSE: SNG), the respiratory drug...
Synairgen to start trial of SNG001 in COVID-19 imminently
18 mars 2020 08h29 HE
|
Synairgen plc
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Synairgen to start trial of SNG001 in COVID-19 imminently Southampton, UK – 18 March 2020: Synairgen plc (LSE: SNG), the respiratory drug...